Drug Shortage Report for RESTASIS MULTIDOSE
Report ID | 194083 |
Drug Identification Number | 02476835 |
Brand name | RESTASIS MULTIDOSE |
Common or Proper name | RESTASIS MULTIDOSE (Cyclosporine Ophthalmic Emulsion, 0.05%w/w) 5.5 mL |
Company Name | ABBVIE CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | CYCLOSPORINE |
Strength(s) | 0.05% |
Dosage form(s) | EMULSION |
Route of administration | OPHTHALMIC OPHTHALMIC |
Packaging size | 10 mL bottle |
ATC code | S01XA |
ATC description | OTHER OPHTHALMOLOGICALS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2023-06-07 |
Estimated end date | 2023-07-28 |
Actual end date | 2023-07-19 |
Shortage status | Resolved |
Updated date | 2023-07-20 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 8401 TRANS-CANADA HIGHWAY SAINT-LAURENT, QUEBEC CANADA H4S 1Z1 |
Company contact information | Should you require any additional information, please contact our Customer Service Department at 1-888-704-8270. |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2023-07-20 | French | Compare |
v5 | 2023-07-20 | English | Compare |
v4 | 2023-06-08 | French | Compare |
v3 | 2023-06-08 | English | Compare |
v2 | 2023-06-08 | French | Compare |
v1 | 2023-06-08 | English | Compare |
Showing 1 to 6 of 6